Login / Signup

Publisher Correction: Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2).

Paolo GisondiAlice B GottliebBoni ElewskiMatthias AugustinSandy McBrideTsen-Fang TsaiChristine de la LogeFrederik FierensJosé M López PintoNicola TiltMark G Lebwohl
Published in: Dermatology and therapy (2023)
Keyphrases
  • clinical trial
  • open label
  • double blind
  • coronary artery disease
  • study protocol
  • case control
  • placebo controlled
  • randomized controlled trial
  • atopic dermatitis